Literature DB >> 16353116

Pathogenesis of implant infections by enterococci.

L Baldassarri1, R Creti, L Montanaro, G Orefici, C R Arciola.   

Abstract

Enterococci are commensals of human and animal intestinal tract that have emerged in the last decades as a major cause of nosocomial infections of bloodstream, urinary tract and in infected surgical sites. Enterococcus faecalis is responsible for ca. 80% of all enterococcal infections while Enterococcus faecium accounts for most of the others; among the most relevant risk factors for development of enterococcal infections is the presence of implanted devices. The pathogenesis of such infections is poorly understood, but several virulence factors have been proposed. Among them, the ability to form biofilm has recently been shown to be one of the most prominent features of this microorganism, allowing colonization of inert and biological surfaces, while protecting against antimicrobial substances, and mediating adhesion and invasion of host cells and survival within professional phagocytes. Biofilm formation has been shown to be particularly important in the development of prosthetic valve enterococcal endocarditis and stent occlusion. Enterococci are also able to express other surface factors that may support colonization of both inert and biological surfaces, and that may be involved in the invasion of, and survival within, the host cell.

Entities:  

Mesh:

Year:  2005        PMID: 16353116     DOI: 10.1177/039139880502801107

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  9 in total

1.  Extracellular gelatinase of Enterococcus faecalis destroys a defense system in insect hemolymph and human serum.

Authors:  Shin Yong Park; Kyoung Mi Kim; Joon Ha Lee; Sook Jae Seo; In Hee Lee
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

2.  Surface protein EF3314 contributes to virulence properties of Enterococcus faecalis.

Authors:  Roberta Creti; Francesca Fabretti; Stefanie Koch; Johannes Huebner; Danielle A Garsin; Lucilla Baldassarri; Lucio Montanaro; Carla Renata Arciola
Journal:  Int J Artif Organs       Date:  2009-09       Impact factor: 1.595

3.  Antimicrobial effect of Lippia sidoides and thymol on Enterococcus faecalis biofilm of the bacterium isolated from root canals.

Authors:  H N H Veras; F F G Rodrigues; M A Botelho; I R A Menezes; H D M Coutinho; J G M da Costa
Journal:  ScientificWorldJournal       Date:  2014-02-06

4.  Prevalence and antimicrobial susceptibility pattern of Enterococcus species isolated from different clinical samples at Black Lion Specialized Teaching Hospital, Addis Ababa, Ethiopia.

Authors:  Zelalem Tena Ferede; Kassu Desta Tullu; Solomon Gizaw Derese; Addisu Gize Yeshanew
Journal:  BMC Res Notes       Date:  2018-11-06

5.  Matrix metalloprotease-1 inhibits and disrupts Enterococcus faecalis biofilms.

Authors:  Lokender Kumar; Christopher R Cox; Susanta K Sarkar
Journal:  PLoS One       Date:  2019-01-11       Impact factor: 3.240

6.  Purification and characterization of bacteriocins-like inhibitory substances from food isolated Enterococcus faecalis OS13 with activity against nosocomial enterococci.

Authors:  Ahmed O El-Gendy; Dag A Brede; Tamer M Essam; Magdy A Amin; Shaban H Ahmed; Helge Holo; Ingolf F Nes; Yara I Shamikh
Journal:  Sci Rep       Date:  2021-02-15       Impact factor: 4.379

7.  Surgical site infection at chest tube drainage site following pulmonary resection for malignant lesions.

Authors:  Takashi Akiyama; Motoki Yano; Hiroki Numanami; Masayuki Yamaji; Rumiko Taguchi; Chihiro Furuta; Yuka Kitagawa; Rintaro Imazu; Masayuki Haniuda
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 2.895

8.  Antibiogram Pattern and Virulence Trait Characterization of Enterococcus Species Clinical Isolates in Eastern India: A Recent Analysis.

Authors:  Srujana Mohanty; Bijayini Behera
Journal:  J Lab Physicians       Date:  2022-07-26

9.  A novel bacteriocin from Enterococcus faecalis 478 exhibits a potent activity against vancomycin-resistant enterococci.

Authors:  Uraporn Phumisantiphong; Kanokrat Siripanichgon; Onrapak Reamtong; Pornphan Diraphat
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.